Literature DB >> 27980080

Difficulties in administration of oral medication formulations to pet cats: an e-survey of cat owners.

M Sivén1, S Savolainen2, S Räntilä1, S Männikkö3, M Vainionpää2, S Airaksinen1, M Raekallio2, O Vainio2, A M Juppo1.   

Abstract

The purpose here was to determine the problems cat owners encounter in medicating their cats with orally administered drugs at home. The study was carried out as an open e-questionnaire survey addressed to cat owners in which the authors focused on the oral administration route. A total of 46 completed questionnaires were included in the survey. In the study, 46 cats received 67 orally administered drugs. Approximately half of the drugs were registered for use in cats by the European Medicines Agency (54 per cent), and there were also off-label drugs registered for human (36 per cent) and canine medication (7.4 per cent) and an ex tempore drug (3.0 per cent). The owners were unable to give the doses as prescribed for their cats for one-fourth of the medications (16/67). Drugs that were registered for feline medication were significantly more palatable than drugs registered for other species (odds ratio (OR) 4.9), and liquid formulations were significantly more palatable than solid formulations (OR 4.8). However, most of the owners (22/38) preferred a solid dosage form, while few (4/38) chose a liquid formulation. The results indicate that there is still a need for more palatable and easily administered oral drugs for cats. British Veterinary Association.

Entities:  

Keywords:  Cats; Companion animals; Drug administration; Medicines; Surveys

Mesh:

Year:  2016        PMID: 27980080     DOI: 10.1136/vr.103991

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Elucidating the Splitting Behavior of Tablets to Optimize the Pharmacotherapy in Veterinary Medicine.

Authors:  Giselle R Bedogni; Felipe Q Pires; Juliano A Chaker; Livia L Sa-Barreto; Katia Seremeta; Nora Okulik; Claudio J Salomon; Marcilio Cunha-Filho
Journal:  AAPS PharmSciTech       Date:  2021-02-07       Impact factor: 3.246

2.  Feline sporotrichosis: a case series of itraconazole-resistant Sporothrix brasiliensis infection.

Authors:  Ceres Cristina Tempel Nakasu; Stefanie Bressan Waller; Márcia Kutscher Ripoll; Marcos Roberto Alves Ferreira; Fabrício Rochedo Conceição; Angelita Dos Reis Gomes; Luiza da Gama Osório; Renata Osório de Faria; Marlete Brum Cleff
Journal:  Braz J Microbiol       Date:  2020-05-09       Impact factor: 2.476

3.  Acceptability of flavoured pharmaceutically non-active mini-tablets in pet cats tested with a rapid 3-portal acceptance test with and without food.

Authors:  S Savolainen; J Hautala; J Junnila; S Airaksinen; A M Juppo; M Raekallio; O Vainio
Journal:  Vet Anim Sci       Date:  2019-03-01

4.  Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats.

Authors:  Margaret E Gruen; Jamie A E Myers; Jezaniah-Kira S Tena; Csilla Becskei; Dawn M Cleaver; B Duncan X Lascelles
Journal:  J Vet Intern Med       Date:  2021-11-01       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.